company background image
AN1 logo

Anagenics ASX:AN1 Stock Report

Last Price

AU$0.008

Market Cap

AU$3.7m

7D

0%

1Y

-63.6%

Updated

09 Oct, 2024

Data

Company Financials

AN1 Stock Overview

Operates as a health and beauty tech company in Australia, New Zealand, and internationally.

AN1 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Anagenics Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Anagenics
Historical stock prices
Current Share PriceAU$0.008
52 Week HighAU$0.026
52 Week LowAU$0.006
Beta-1.03
11 Month Change0%
3 Month Change0%
1 Year Change-63.64%
33 Year Change-87.30%
5 Year Change-96.00%
Change since IPO-99.79%

Recent News & Updates

Recent updates

How Much is Cellmid's (ASX:CDY) CEO Getting Paid?

Dec 17
How Much is Cellmid's (ASX:CDY) CEO Getting Paid?

Shareholder Returns

AN1AU Personal ProductsAU Market
7D0%-5.1%-0.5%
1Y-63.6%75.6%16.0%

Return vs Industry: AN1 underperformed the Australian Personal Products industry which returned 75.6% over the past year.

Return vs Market: AN1 underperformed the Australian Market which returned 16% over the past year.

Price Volatility

Is AN1's price volatile compared to industry and market?
AN1 volatility
AN1 Average Weekly Movementn/a
Personal Products Industry Average Movement13.3%
Market Average Movement8.8%
10% most volatile stocks in AU Market17.4%
10% least volatile stocks in AU Market3.6%

Stable Share Price: AN1's share price has been volatile over the past 3 months compared to the Australian market.

Volatility Over Time: Insufficient data to determine AN1's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2004n/aKaren Matthewsanagenics.com

Anagenics Limited operates as a health and beauty tech company in Australia, New Zealand, and internationally. It develops and sells FGF5 inhibitor formulations; over-the-counter (OTC), cosmetic antiaging, and longevity targeting products; and imports and distributes international and local skin care and wellbeing products under the Thalgo, Hydro Peptide, Comfort Zone, Priori, and Inika Organic brand names. The company also develops, manufactures, and markets beauty and wellness brands comprising Uspa and evolis.

Anagenics Limited Fundamentals Summary

How do Anagenics's earnings and revenue compare to its market cap?
AN1 fundamental statistics
Market capAU$3.69m
Earnings (TTM)-AU$7.28m
Revenue (TTM)AU$10.80m

0.3x

P/S Ratio

-0.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AN1 income statement (TTM)
RevenueAU$10.80m
Cost of RevenueAU$6.44m
Gross ProfitAU$4.36m
Other ExpensesAU$11.65m
Earnings-AU$7.28m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.016
Gross Margin40.37%
Net Profit Margin-67.43%
Debt/Equity Ratio10.0%

How did AN1 perform over the long term?

See historical performance and comparison